029HO12398 TENNYSON

Print/PDF
Registration Name BURLANE TENNYSON
Registration Number HOGBR000000618668
Primary NAAB Code 029HO12398
Secondary Code(s) 529HO12398
Status Inactive
Controller Name ABS Global (29)
Date of Birth 1/20/2003
aAa 132
DMS -
GFI 6.5%
Genetic Codes * TV TY
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire DELLKA JUROR GORDON-TW
MGS CAROL PRELUDE MTOTO-ET
Beta Casein A1A2
Kappa Casein -
Beta Lactoglobulin AB
INDEXES
NM$ -256, 91% R CM$ -273
NM Percentile 11% FM$ -218
GTPI 2047 GM$ -249
PRODUCTION TRAITS
21821 Dtrs 3769 herds 11 % US 99% R
Milk 118 Fat, % -15 , -0.08%
SCS 3.01, 99% R Protein, % -8 , -0.04%
Feed Saved -33 , 53% R Milking Speed 6.96 , 60% R
Health & Fertility
Productive Life -2.3      98% R Mastitis -0.4      91% R
Heifer Livability 0.5       68% R Metritis -0.6      85% R
Livability -2.8      93% R D. Abom -1.4      89% R
DPR -1.0      99% R Ketosis -2.2      85% R
FSC -6.6      99% R R. Placenta -0.1      85% R
HCR 2.1      93% R Milk Fever 0.1      71% R
CCR -1.0      99% R
SCR -        -
DIA 0.1      39% R
RSP 0.1      45% R
Calving Traits
Sire CE 1.6      99% R 16731 Obs
Daughter CE 1.9      97% R 4466 Obs, 7050 Dtrs
Sire SB 4.1      97% R 12025 Obs
Daughter SB 4.5      97% R 3599 Obs, Dtrs
Gestation Length 0.2      99% R 343 Obs, 6167 Dtrs
Early First Calving 4.6      98% R 221 Obs, 2214 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
4791 Dtrs 1519 herds 94% R
PTA Type -1.88 UDC -2.30
HCC -1.78 BWC 0.11
FLC -1.31
Linear Traits
Stature -1.05
Short
Strength -0.10
Weak
Body Depth -0.42
Shallow
Dairy Form -0.83
Closed
Rump Angle 1.07
Sloped
Thurl Width 0.41
Sloped
Rear Legs-Side View 0.41
Wide
Rear Legs-Rear View -1.45
H.-in
Foot Angle -1.53
Low
Feet & Legs Score -1.41
Low
F.U. Attachment 0.28
Curved
Rear Udder Height -2.21
Low
Rear Udder Width -2.43
Narrow
Udder Cleft -1.50
Weak
Udder Depth -1.45
H.-in
Front Teat Placement -1.94
Wide
Rear Teat Placement -1.82
Wide
Teat Length 1.35
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO